Objectives: To test the performance of different analytical approaches in highlighting the occurrence of deregulated redox status in various physio-pathological situations. : 35 light and 61 heavy smokers, 19 chronic renal failure, 59 kidney transplanted patients, and 87 healthy controls were retrospectively considered for the study.
Introduction
Oxidative stress plays a role in different human pathological conditions; it is caused by an imbalance between reactive oxidants (endogenous and exogenous) and antioxidant defense systems [1] [2] [3] [4] [5] . Measuring the body's reaction to oxidants' attack is clinically useful to disclose possible oxidative imbalances, depletion of antioxidant defenses, disease progression and response to medical treatment. To this purpose, different biomarkers have been proposed as indexes of lipid peroxidation (hydroperoxides, dienes, F2-isoprostanes, malondialdehyde) and/or various endogenous antioxidant compounds (e.g., thiol groups, Vit A, Vit E, antioxidant enzymes) [6] . Ideally these methods should be used synergistically rather than as homologous competitive oxidative stress biomarkers, however this is unfeasible from the practical point of view, so it is important to distinguish the most suitable one for the diverse indications.
MDA, the most abundant lipid peroxidation end-product, arising from the attack of ROS on PUFAs with at least 3 double bonds, is present both in a free form (F-MDA) chemically active and a potentially damaging agent, and bound (B-MDA) to nucleophilic groups (SH or NH 2 ) of proteins and lipoproteins, indicative of an older injury and excreted by urine [7, 8] .
Usually MDA is determined by reaction with thiobarbituric acid as thiobarbituric acidreactive substances (TBARS), an assay not totally specific because other aldehydes rather than MDA can be quantified [1, 3, [5] [6] [7] 9] . Moreover, the standard TBARs procedure measures only total MDA (T-MDA), i.e. the sum of F-MDA and B-MDA, while for F-MDA evaluation, a proteins precipitation step is needed before the derivatization reaction.
Nonetheless, a new assay has been developed which exhibits high specificity and sensitivity both for free and protein bound MDA [10] .
According to the European Food Safety Authority (EFSA), MDA could be used as an index of oxidative damage if appropriate techniques are available for its quantification [11] .
The high metrological level method based on gas chromatography-mass spectrometry with isotope dilution (ID-GC-MS) [12] allows both the direct measurement of F-and T-MDA concentrations, avoiding proteins precipitation. The indirect measurement of B-MDA is calculated as the difference between the total and free MDA amounts. The use of dideuterated MDA as internal standard suppresses bias occurring during hydrolysis, derivatization, extraction, and ensures the accuracy of the analytical process by adequate calibration curves. The attempt to search for an alternative non deuterated internal standard seems also hopeful [13, 14] .
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Despite this highly sensitive and specific technique is expensive, time-consuming and affordable by a limited number of specialized laboratories, it may be conveniently used to confirm the results obtained by other simpler methods, more rugged and workable in a clinical routine.
Some commercial assays are available either to provide a global picture of several potentially harmful oxidant compounds (deriving from a large class of biological molecules after the radicals' attack) or to assess the serum/plasma barrier to oxidation, as total antioxidant capacity (TAC) [3, [15] [16] [17] [18] [19] [20] [21] [22] . These assays allow to measure oxidative status in a quicker and easier way and are suitable for routine applications in a clinical laboratory setting.
In our previous paper on critically ill patients in intensive care units [23] , the sensitivity of the commercial assay (d-ROMs, Reactive Oxygen Metabolites), which determines hydroperoxides, an acute intermediate product arising from the attack of ROS on PUFAs [24, 25] , was reported to be lower than MDA determination by ID-GC-MS [12] . The poor performance of dROMs test [23] was attributed to many factors such as the small number of patients enrolled in the study, their highly critical conditions and the complex concurrent pharmacological treatment. The unsatisfactory performance of d-ROMs was in agreement with the reports of some authors [16, 19] , but in marked contrast to the findings of other groups, who introduced the same assay for clinical routine measurements [15, 17, 18, [20] [21] [22] [24] [25] [26] [27] .
Here we present a retrospective study on light and heavy smokers (LS, HS), chronic renal failure patients (CRF) and kidney transplant patients (KP), in order to ascertain the suitability of F-MDA, B-MDA, T-MDA, d-ROMs and TAC tests in different clinical settings characterized by oxidative stress. Thus, results from previous clinical studies [26, [28] [29] [30] , have been collected and statistically compared for the first time, with the aim to search for the best marker and/or assay and to verify their performance in evidencing oxidative stress.
Materials and Methods

Subjects
The subjects analyzed in this study had been previously enrolled for different research projects approved by the local Institutional Ethics Committee and carried out according to the guidelines of the Helsinki Declaration. Written informed consent was obtained from all the subjects fulfilling the inclusion criteria.
Written consent was obtained from all the subjects fulfilling the inclusion criteria. (cerebral ischemia, atrial fibrillation, angina) and patients with mellitus diabetes diabetes mellitus at the time of transplant [26] . The concentrations of all MDA forms in KT patients were never published before. No healthy controls were enrolled in this study.
Samples collection
Peripheral venous blood samples were drawn after overnight fasting; 2 blood specimens from each patient were collected in light protected tubes, either with no additive for serum dROMs and total antioxidant capacity (TAC) measurement or containing ethylenediaminethetraacetic acid (EDTA) to prevent coagulation. EDTA specimens were immediately centrifuged to obtain plasma samples for MDA determination. All samples were frozen and stored at -80 °C until biochemically measured.
Analytical methods
Serum reactive oxygen metabolites were measured by a spectrophotometric method using the d-ROMs test commercial kit on FREE analyzer (Diacron International, Grosseto, Italy), as previously described [17, 28] . Serum TAC was measured by a spectrophotometric method using the OXY-Adsorbent test commercial kit on FREE analyzer (Diacron International, Grosseto, Italy), as previously described [26] . The test is based on the ability of hypochlorous acid (HClO) to oxidize the physiologic antioxidants (uric acid, glutathione, thiol groups, vitamins, glutathione peroxidase, superoxide dismutase and catalase). As HClO reacts with a correctly buffered chromogenic substrate, it forms a coloured complex that can be measured photometrically at 505 or 546 nm. The concentration of the coloured complex is directly proportional to the concentration of HClO and indirectly proportional to the antioxidant ability of the sample.
The analytical imprecision of the test is: CV within-run 1.90%; CV between-run 2.05%.
Plasma free and total MDA were measured following the procedures described by Cighetti et al. [12] . For free MDA, plasma (0. For total MDA, plasma (0.2 mL), added with dideuterated MDA (0.25 nmol) as internal standard, was hydrolyzed in 1 mol/L NaOH at 60 °C for 60 minutes, then treated as described for free MDA. Bound MDA fraction was calculated as the difference between total and free MDA. The addition of butylated hydroxytoluene to the plasma samples as antioxidant and the low temperature for hydrolysis and derivatization reactions avoid the formation of interfering compounds. Moreover, the use of dideuterated MDA added to the biological samples as internal standard before any pre-analytical step, together with the availability of synthesized, purified and crystallized MDA, allows the measurement of true free and total MDA values using adequately prepared calibration curves [12] . The analytical imprecision of the assay is:
CV within-run and between-run 1.0 and 1.2% for F-MDA, 0.9 and 1.1% for T-MDA, respectively. The laboratory cut-off for free-and total MDA is 0.50 and 2.10 µmol/L, respectively, derived from the mean +2SD of 500 determinations in healthy subjects enrolled over 10 years in different clinical studies (data not shown).
Statistical analyses and Methods comparison
The performance of the assays, indicating the ability to discriminate between subjects with [34] . The strength of association between variables, for data not normally distributed, was identified by the robust pairwise Spearman's coefficient and the corresponding 95% Confidence Intervals (CI). Post-hoc power analysis has been performed using the pwr libraries [35] . The power analysis and the significance were set at 0.8 and p <0.05, respectively. The strength of correlations among the markers obtained by pairwise Spearman test is reported in Table 2 . T-MDA showed a significant correlation with all the variables examined except with TAC. Interestingly T-MDA seems stronger related with d-ROMs than with F-MDA. F-MDA is the only MDA form which correlates with TAC (negative weak correlation). dROMs and TAC do not correlate.
Results
Groups
Discussion
Several methods exists for monitoring oxidative status in physio-pathological, nutritional or living conditions, however the poor performance of the commercial assays and their inadequacy to distinguish between healthy controls and patients is still under debate, and results obtained by different analytical methods are often difficult to compare [19, 35 36] .
Nevertheless, the use of commercial kits tested in the present study is still widespread among clinical and research laboratories for their simplicity of use and the low cost, so an additional study on their performance in different clinical settings merits attention.
In this retrospective study, we evaluated the performance of two commercial assays, d-ROMs and TAC, which measure "families" of parameters involved in oxidative stress, to study the Of all the measured parameters (Figure 1 ), only T-MDA confirmed the lack of oxidative stress in healthy controls and the presence of oxidative damage in all the four studied groups with different severity from light smokers to CRF patients. The T-MDA excellent performance was confirmed by the highest accuracy for both sensitivity and specificity (100%) as evidenced by ROC curve analyses. Consequently, we compared all the methods for the assessment of oxidative status against T-MDA, considered as our reference index (gold standard).
Very different information was provided by the other assays. As concerns as F-MDA, it was unable to show CRF groups increased oxidative status (Figure 1 ). However, its outcome in CRF group is not totally surprising as F-MDA, much lower than T-MDA (less than 10%), is highly reactive and may be expected to be variable and not cumulative. Thus, the biochemical meaning of the different MDA forms needs further speculation to explain for the significant, but not strong correlations, between F-MDA and both B-and T-MDA ( Table 2 ). The endogenous F-MDA levels depend on the balance between MDA formation and its detoxification as B-MDA, cleared by kidneys in urine after its transformation from protein-MDA adducts to simpler MDA-adducts by proteolytic enzymes [8] . Thus, increased T-MDA is not only indicative of increased lipid peroxidation in all pathological conditions, but can also arise from reduced kidney functionality, as in chronic renal insufficiency and in dialysis patients [29] , leading to the B-MDA values in CRF higher than other groups (Figure 1) .
Similarly, unchanged F-MDA concentration is not only indicative of the lack of lipid peroxidation, but also represents the MDA amount remaining after F-MDA conjugation with proteins and aminoacids [7, 8] . Therefore, all the three MDA forms must be considered to frame the true oxidative status of a sample [29] .
Concerning the d-ROMs test accuracy, its specificity was close to T-MDA in identifying true negative values, while its sensitivity was weaker (Table 1) . This assay was able to reveal reported by some authors [15, 18, [20] [21] [22] , or the lack of its performance as reported by others [1, 16, 19, 23] . Notably, the d-ROMs test showed weak but significant correlations with the MDA forms evaluated by ID-GC-MS (Table 2) , although these assays are based on totally different principles.
Poor performance was observed for TAC assay showing the lowest sensitivity and AUC area (Table 1) . Nevertheless, in all the groups except KT patients, this assay evidenced a disrupted serum antioxidant barrier (Figure 1 ), as a consequence of endogenous antioxidants consumption to counteract the formation and/or attack of free radicals. The preserved total antioxidant steady-state in KT patients, despite a pro-oxidant environment as evidenced by all the other tests, suggests the presence of either a basal stronger protection than in other groups, or some analytical interference due to co-administered pharmacological therapies.
Thus, the evaluation of antioxidant ability alone might not be sufficient to identify the change in oxidative status but needs to be accompanied by other assays [16 40] .
Study limitations: a) Comparison between MDA levels by ID-GC-MS and those resulting from the HPLC-TBAs assay has not been included. b) In the clinical studies considered for the present retrospective analysis [26, 28, 29, 30] , the evaluation of plasma Vitamin E was never carried out as the changing of oxidative status was detected by total and reduced glutathione, cysteine, homocysteine and cysteinylglycine. On the other hand, when Vitamin E was measured [37] , in contrast to significant increase in F-MDA and reduction in GSH, no significant changes of both alfa-and gamma tocopherol (the two Vit E isoforms) were observed in patients vs controls.
In conclusion, the results of this retrospective study show that T-MDA, quantified by ID-GC-MS method, is, among the evaluated markers or assays, the best index for evidencing oxidative stress. Our study also confirms the ability of the d-ROMs test to show modified serum oxidative status particularly in the presence of high damages and evidences the poor sensitivity of TAC assay. These two commercial assays are easy to perform, suitable for screening tests and useful for routine clinical purposes. Moreover, they give the possibility of assessing simultaneously the balance/unbalance of oxidative status. In case of critical clinical conditions, a more reliable and sensitive assay should be mandatory. Validation of routine against the "gold standard method" could help biochemists to acquire accurate data for intralaboratory standardization and clinicians to evaluate data more correctly.
